From Forbes: "New England Journal Charges Merck Deleted Vioxx Study Data," by Amanda Gardner--
The editors at one of the world's leading medical journals have accused researchers and Vioxx manufacturer Merck & Co. of withholding key heart risk data that showed up in one of the first large trials of the now-withdrawn arthritis painkiller.
Specifically, the editors of the New England Journal of Medicine charged that a major study published in November 2000 was submitted to the journal after information about three heart attacks among Vioxx trial participants was deleted by Merck, which funded the study.
--Posted by Illinois Vioxx attorney T. Evan Schaeffer of Madison County Illinois PI law firm Schaeffer & Lamere, P.C.
Comments